Mary C. Smith Fawzi, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression | 13 | 2022 | 8132 | 1.240 |
Why?
|
| Growth Disorders | 4 | 2020 | 634 | 1.010 |
Why?
|
| HIV Infections | 19 | 2022 | 17337 | 0.950 |
Why?
|
| Psychotherapy, Group | 2 | 2020 | 413 | 0.840 |
Why?
|
| Tanzania | 12 | 2022 | 1390 | 0.750 |
Why?
|
| Haiti | 13 | 2021 | 550 | 0.700 |
Why?
|
| Social Support | 6 | 2020 | 2174 | 0.700 |
Why?
|
| Caregivers | 4 | 2015 | 2241 | 0.690 |
Why?
|
| Spouse Abuse | 2 | 2021 | 182 | 0.640 |
Why?
|
| Sexual Partners | 5 | 2021 | 800 | 0.630 |
Why?
|
| Child Nutrition Disorders | 2 | 2020 | 139 | 0.630 |
Why?
|
| Mental Health | 8 | 2021 | 3251 | 0.590 |
Why?
|
| Perinatal Care | 1 | 2020 | 244 | 0.570 |
Why?
|
| Child Development | 3 | 2018 | 2300 | 0.560 |
Why?
|
| Anxiety | 6 | 2021 | 4570 | 0.540 |
Why?
|
| Internal-External Control | 2 | 2015 | 358 | 0.520 |
Why?
|
| Rural Population | 7 | 2021 | 2276 | 0.510 |
Why?
|
| Depression, Postpartum | 2 | 2019 | 349 | 0.510 |
Why?
|
| Adaptation, Psychological | 4 | 2015 | 2629 | 0.480 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 561 | 0.480 |
Why?
|
| Risk-Taking | 1 | 2020 | 1037 | 0.470 |
Why?
|
| Adolescent Behavior | 2 | 2015 | 1187 | 0.450 |
Why?
|
| HIV | 1 | 2020 | 1579 | 0.430 |
Why?
|
| Life Change Events | 1 | 2018 | 952 | 0.430 |
Why?
|
| Child of Impaired Parents | 1 | 2016 | 460 | 0.420 |
Why?
|
| Anti-Retroviral Agents | 3 | 2020 | 1782 | 0.420 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2022 | 2149 | 0.410 |
Why?
|
| Self Disclosure | 1 | 2013 | 249 | 0.390 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2014 | 351 | 0.390 |
Why?
|
| Socioeconomic Factors | 10 | 2020 | 7798 | 0.390 |
Why?
|
| Students | 2 | 2018 | 1733 | 0.370 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2016 | 1894 | 0.370 |
Why?
|
| Women's Rights | 1 | 2011 | 65 | 0.360 |
Why?
|
| Water Supply | 1 | 2011 | 204 | 0.350 |
Why?
|
| Suicidal Ideation | 1 | 2019 | 1447 | 0.330 |
Why?
|
| Rwanda | 5 | 2020 | 656 | 0.330 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 1509 | 0.330 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 959 | 0.320 |
Why?
|
| Human Rights | 1 | 2011 | 309 | 0.310 |
Why?
|
| Malnutrition | 1 | 2014 | 622 | 0.300 |
Why?
|
| Health Priorities | 1 | 2011 | 375 | 0.300 |
Why?
|
| Prevalence | 9 | 2021 | 15689 | 0.290 |
Why?
|
| Nutritional Status | 2 | 2019 | 1596 | 0.290 |
Why?
|
| Family | 4 | 2015 | 3193 | 0.280 |
Why?
|
| Health Services Accessibility | 8 | 2020 | 5430 | 0.270 |
Why?
|
| Cross-Sectional Studies | 12 | 2021 | 26049 | 0.270 |
Why?
|
| Students, Nursing | 1 | 2006 | 45 | 0.270 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2018 | 4575 | 0.260 |
Why?
|
| Adolescent | 21 | 2021 | 88234 | 0.250 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 2518 | 0.250 |
Why?
|
| Emergencies | 1 | 2012 | 1217 | 0.250 |
Why?
|
| Counseling | 2 | 2013 | 1538 | 0.250 |
Why?
|
| Medication Adherence | 1 | 2016 | 2174 | 0.240 |
Why?
|
| Rural Health | 1 | 2006 | 296 | 0.230 |
Why?
|
| Rape | 1 | 2005 | 131 | 0.230 |
Why?
|
| Refugees | 1 | 2012 | 595 | 0.220 |
Why?
|
| Tuberculosis | 4 | 2023 | 2015 | 0.220 |
Why?
|
| Depressive Disorder | 6 | 2021 | 3735 | 0.220 |
Why?
|
| Anti-HIV Agents | 3 | 2016 | 4524 | 0.220 |
Why?
|
| Female | 42 | 2022 | 392148 | 0.220 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 4 | 2005 | 934 | 0.210 |
Why?
|
| Chlamydia Infections | 1 | 2006 | 365 | 0.200 |
Why?
|
| Quality of Life | 5 | 2021 | 13347 | 0.200 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 4764 | 0.200 |
Why?
|
| Cognition | 2 | 2016 | 6987 | 0.200 |
Why?
|
| Gonorrhea | 1 | 2006 | 346 | 0.190 |
Why?
|
| Young Adult | 11 | 2021 | 59179 | 0.190 |
Why?
|
| Women's Health | 1 | 2011 | 2065 | 0.190 |
Why?
|
| Psychology | 2 | 2016 | 356 | 0.190 |
Why?
|
| Poverty | 5 | 2021 | 2692 | 0.190 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2022 | 1351 | 0.190 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2005 | 661 | 0.190 |
Why?
|
| Rural Health Services | 1 | 2005 | 384 | 0.180 |
Why?
|
| United Nations | 2 | 2011 | 149 | 0.180 |
Why?
|
| Infant | 9 | 2020 | 36152 | 0.180 |
Why?
|
| Developing Countries | 5 | 2016 | 2867 | 0.180 |
Why?
|
| Parents | 2 | 2015 | 3563 | 0.170 |
Why?
|
| Child, Preschool | 10 | 2020 | 42188 | 0.170 |
Why?
|
| Humans | 52 | 2023 | 760617 | 0.170 |
Why?
|
| Africa South of the Sahara | 2 | 2019 | 745 | 0.170 |
Why?
|
| Adult | 28 | 2022 | 220969 | 0.160 |
Why?
|
| Mobile Health Units | 1 | 2020 | 92 | 0.160 |
Why?
|
| Male | 29 | 2021 | 360358 | 0.160 |
Why?
|
| Vitamins | 1 | 2007 | 1635 | 0.160 |
Why?
|
| Educational Status | 2 | 2016 | 2509 | 0.150 |
Why?
|
| Mental Disorders | 3 | 2017 | 6826 | 0.150 |
Why?
|
| Psychological Tests | 1 | 2020 | 639 | 0.140 |
Why?
|
| Social Stigma | 2 | 2016 | 769 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2005 | 1914 | 0.140 |
Why?
|
| Cross Infection | 1 | 2006 | 1422 | 0.140 |
Why?
|
| Residence Characteristics | 3 | 2016 | 2090 | 0.140 |
Why?
|
| Pregnancy | 9 | 2022 | 29868 | 0.130 |
Why?
|
| Demography | 2 | 2020 | 1643 | 0.130 |
Why?
|
| Risk Factors | 11 | 2021 | 74115 | 0.130 |
Why?
|
| Psychological Techniques | 1 | 2016 | 48 | 0.130 |
Why?
|
| Policy | 1 | 2020 | 506 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2021 | 636 | 0.130 |
Why?
|
| Earthquakes | 1 | 2018 | 191 | 0.130 |
Why?
|
| Peru | 4 | 2006 | 890 | 0.130 |
Why?
|
| Personality Inventory | 2 | 1998 | 1018 | 0.120 |
Why?
|
| Multivariate Analysis | 4 | 2014 | 12043 | 0.120 |
Why?
|
| Community-Based Participatory Research | 1 | 2016 | 220 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2007 | 3411 | 0.110 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2016 | 256 | 0.110 |
Why?
|
| School Health Services | 1 | 2017 | 384 | 0.110 |
Why?
|
| Prisoners | 1 | 1997 | 314 | 0.110 |
Why?
|
| Students, Medical | 1 | 2006 | 1934 | 0.110 |
Why?
|
| Eritrea | 1 | 2012 | 4 | 0.100 |
Why?
|
| Schools | 2 | 2018 | 1483 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2017 | 2567 | 0.100 |
Why?
|
| Child | 10 | 2020 | 80079 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2019 | 2697 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2016 | 2197 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2021 | 1420 | 0.100 |
Why?
|
| Occupations | 2 | 2005 | 516 | 0.100 |
Why?
|
| Sexual Behavior | 2 | 2020 | 2187 | 0.100 |
Why?
|
| Middle Aged | 17 | 2021 | 220584 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 4007 | 0.100 |
Why?
|
| Child, Orphaned | 1 | 2012 | 55 | 0.100 |
Why?
|
| Sanitation | 1 | 2011 | 82 | 0.090 |
Why?
|
| Age Factors | 4 | 2019 | 18381 | 0.090 |
Why?
|
| Politics | 2 | 1998 | 813 | 0.090 |
Why?
|
| Uganda | 1 | 2016 | 1332 | 0.090 |
Why?
|
| Healthy People Programs | 1 | 2011 | 54 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39063 | 0.090 |
Why?
|
| Mothers | 2 | 2019 | 2194 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 704 | 0.090 |
Why?
|
| Consumer Advocacy | 1 | 2011 | 82 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 6016 | 0.090 |
Why?
|
| Alcoholism | 1 | 2021 | 1972 | 0.090 |
Why?
|
| Self-Help Groups | 1 | 2012 | 192 | 0.090 |
Why?
|
| Prospective Studies | 6 | 2017 | 54360 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 2723 | 0.090 |
Why?
|
| Ethiopia | 1 | 2012 | 460 | 0.090 |
Why?
|
| Cost of Illness | 2 | 2017 | 1935 | 0.080 |
Why?
|
| HIV-1 | 1 | 2007 | 6858 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2017 | 8618 | 0.080 |
Why?
|
| Teaching | 1 | 2017 | 1169 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 3194 | 0.080 |
Why?
|
| Health Surveys | 2 | 2016 | 4037 | 0.080 |
Why?
|
| Health Status | 2 | 2019 | 4075 | 0.080 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 645 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2014 | 9311 | 0.080 |
Why?
|
| Maternal Mortality | 1 | 2011 | 301 | 0.080 |
Why?
|
| Sex Factors | 2 | 2019 | 10548 | 0.070 |
Why?
|
| Income | 1 | 2016 | 1870 | 0.070 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 238 | 0.070 |
Why?
|
| Antibiotics, Antitubercular | 2 | 2004 | 99 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 1700 | 0.070 |
Why?
|
| Goals | 1 | 2011 | 708 | 0.060 |
Why?
|
| Mass Screening | 2 | 2023 | 5424 | 0.060 |
Why?
|
| Algorithms | 1 | 2006 | 14018 | 0.060 |
Why?
|
| Health Education | 1 | 2012 | 1049 | 0.060 |
Why?
|
| Antitubercular Agents | 2 | 2004 | 1374 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 761 | 0.060 |
Why?
|
| Social Class | 2 | 2011 | 1992 | 0.060 |
Why?
|
| India | 1 | 2011 | 2286 | 0.060 |
Why?
|
| Checklist | 1 | 2012 | 827 | 0.060 |
Why?
|
| Health Services | 1 | 2010 | 751 | 0.060 |
Why?
|
| Child Health Services | 1 | 2010 | 644 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2016 | 26180 | 0.060 |
Why?
|
| International Cooperation | 1 | 2011 | 1421 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10073 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2016 | 9643 | 0.060 |
Why?
|
| Cycloserine | 1 | 2004 | 118 | 0.060 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2004 | 99 | 0.050 |
Why?
|
| Lesotho | 1 | 2023 | 73 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2020 | 4668 | 0.050 |
Why?
|
| Isoniazid | 1 | 2005 | 283 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2011 | 2486 | 0.050 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2014 | 831 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4416 | 0.050 |
Why?
|
| Rifampin | 1 | 2005 | 339 | 0.050 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 5332 | 0.050 |
Why?
|
| Risk | 1 | 2015 | 9604 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3680 | 0.050 |
Why?
|
| Health Policy | 2 | 2014 | 2682 | 0.050 |
Why?
|
| Linear Models | 1 | 2012 | 5866 | 0.050 |
Why?
|
| AIDS Serodiagnosis | 1 | 2001 | 219 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2017 | 64568 | 0.040 |
Why?
|
| Vietnam | 2 | 1998 | 406 | 0.040 |
Why?
|
| Boston | 2 | 2006 | 9313 | 0.040 |
Why?
|
| Infection Control | 1 | 2006 | 982 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 756 | 0.040 |
Why?
|
| Health Promotion | 1 | 2011 | 2206 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2006 | 22148 | 0.040 |
Why?
|
| Financing, Organized | 1 | 2020 | 204 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2005 | 1936 | 0.040 |
Why?
|
| Urban Population | 1 | 2006 | 2033 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2019 | 41457 | 0.040 |
Why?
|
| Torture | 1 | 1998 | 67 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2003 | 934 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 1048 | 0.040 |
Why?
|
| Focus Groups | 1 | 2023 | 1409 | 0.040 |
Why?
|
| Sex Offenses | 1 | 2021 | 352 | 0.040 |
Why?
|
| Confidentiality | 1 | 2001 | 608 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 997 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2006 | 6338 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 2315 | 0.030 |
Why?
|
| Community Health Services | 1 | 2001 | 654 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 1998 | 397 | 0.030 |
Why?
|
| Self Report | 2 | 2017 | 3723 | 0.030 |
Why?
|
| Health Resources | 1 | 2001 | 933 | 0.030 |
Why?
|
| Latin America | 1 | 2016 | 407 | 0.030 |
Why?
|
| Asia | 1 | 2016 | 615 | 0.030 |
Why?
|
| Comorbidity | 2 | 2021 | 10505 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2020 | 835 | 0.030 |
Why?
|
| Growth | 1 | 2016 | 365 | 0.030 |
Why?
|
| Education | 1 | 2016 | 534 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12334 | 0.030 |
Why?
|
| Minority Groups | 1 | 2020 | 1202 | 0.030 |
Why?
|
| Cuba | 1 | 2012 | 48 | 0.030 |
Why?
|
| Child Mortality | 1 | 2014 | 199 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4321 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14648 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 14591 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 1988 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20074 | 0.020 |
Why?
|
| Disease Progression | 1 | 2007 | 13495 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2020 | 1717 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2017 | 1648 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2014 | 80566 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2006 | 23972 | 0.020 |
Why?
|
| Psychometrics | 1 | 1997 | 3060 | 0.020 |
Why?
|
| Incidence | 3 | 2004 | 21337 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2017 | 3016 | 0.020 |
Why?
|
| Perception | 1 | 2012 | 1198 | 0.020 |
Why?
|
| Suicide | 1 | 2016 | 1601 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 1438 | 0.010 |
Why?
|
| World Health Organization | 1 | 2010 | 1321 | 0.010 |
Why?
|
| Netherlands | 1 | 2008 | 2221 | 0.010 |
Why?
|
| Directly Observed Therapy | 1 | 2004 | 139 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1504 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2417 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1185 | 0.010 |
Why?
|
| Sputum | 1 | 2004 | 506 | 0.010 |
Why?
|
| Disease Notification | 1 | 2001 | 94 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2004 | 809 | 0.010 |
Why?
|
| National Health Programs | 1 | 2004 | 440 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2010 | 2218 | 0.010 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2004 | 585 | 0.010 |
Why?
|
| Contact Tracing | 1 | 2001 | 270 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 1407 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 39913 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 2475 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 2871 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 169042 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2849 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2004 | 1437 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5239 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 2635 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 5061 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 58894 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4845 | 0.010 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 846 | 0.010 |
Why?
|
| United States | 2 | 2020 | 72272 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6305 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2004 | 2688 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 13245 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10754 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6224 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5491 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15251 | 0.000 |
Why?
|